These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11562570)

  • 1. Inflammatory muscle diseases.
    Hilton-Jones D
    Curr Opin Neurol; 2001 Oct; 14(5):591-6. PubMed ID: 11562570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiopathic inflammatory myopathies.
    Amato AA; Barohn RJ
    Neurol Clin; 1997 Aug; 15(3):615-48. PubMed ID: 9227956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Idiopathic myositis].
    Burgunder JM
    Ther Umsch; 2003 Jul; 60(7):407-12. PubMed ID: 12956034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic inflammatory myopathies.
    Dimachkie MM; Barohn RJ
    Front Neurol Neurosci; 2009; 26():126-146. PubMed ID: 19349710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inflammatory myopathies].
    Cherin P
    Rev Prat; 2001 Feb; 51(3):270-7. PubMed ID: 11265423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on the use of intravenous immune globulin in the treatment of patients with inflammatory muscle disease.
    Dalakas MC
    J Clin Immunol; 1995 Nov; 15(6 Suppl):70S-75S. PubMed ID: 8613495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on Myositis Therapy: From Today's Standards to Tomorrow's Possibilities.
    Glaubitz S; Zeng R; Rakocevic G; Schmidt J
    Curr Pharm Des; 2022; 28(11):863-880. PubMed ID: 34781868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1 expression in inflammatory myopathies: evidence of marked immunoreactivity in sarcoid granulomas and muscle fibres showing ischaemic and regenerative changes.
    Authier FJ; Mhiri C; Chazaud B; Christov C; Cherin P; Barlovatz-Meimon G; Gherardi RK
    Neuropathol Appl Neurobiol; 1997 Apr; 23(2):132-40. PubMed ID: 9160898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cells and the immunopathogenesis of idiopathic inflammatory myopathies.
    de Padilla CM; Reed AM
    Curr Opin Rheumatol; 2008 Nov; 20(6):669-74. PubMed ID: 18946326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermatomyositis with the features of inclusion body myositis associated with carcinoma of the bladder.
    Talanin NY; Bushore D; Rasberry R; Rudolph T; Tuli M; Friedman-Musicante R
    Br J Dermatol; 1999 Nov; 141(5):926-30. PubMed ID: 10583182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired immune and inflammatory myopathies: pathologic classification.
    Pestronk A
    Curr Opin Rheumatol; 2011 Nov; 23(6):595-604. PubMed ID: 21934500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recent topics on inflammatory myositis].
    Hase A; Orimo S; Arahata K
    Nihon Naika Gakkai Zasshi; 1996 Jan; 85(1):123-8. PubMed ID: 8871321
    [No Abstract]   [Full Text] [Related]  

  • 13. New developments in the role of cytokines and chemokines in inflammatory myopathies.
    Lundberg IE; Nyberg P
    Curr Opin Rheumatol; 1998 Nov; 10(6):521-9. PubMed ID: 9812212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inclusion body myositis: clinical and pathological boundaries.
    Amato AA; Gronseth GS; Jackson CE; Wolfe GI; Katz JS; Bryan WW; Barohn RJ
    Ann Neurol; 1996 Oct; 40(4):581-6. PubMed ID: 8871577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inclusion body myositis.
    Dimachkie MM; Barohn RJ
    Neurol Clin; 2014 Aug; 32(3):629-46, vii. PubMed ID: 25037082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory muscle diseases: a critical review on pathogenesis and therapies.
    Dalakas MC
    Curr Opin Pharmacol; 2010 Jun; 10(3):346-52. PubMed ID: 20409756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis.
    Mescam-Mancini L; Allenbach Y; Hervier B; Devilliers H; Mariampillay K; Dubourg O; Maisonobe T; Gherardi R; Mezin P; Preusse C; Stenzel W; Benveniste O
    Brain; 2015 Sep; 138(Pt 9):2485-92. PubMed ID: 26198592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The geoepidemiology of autoimmune muscle disease.
    Prieto S; Grau JM
    Autoimmun Rev; 2010 Mar; 9(5):A330-4. PubMed ID: 19906360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MHC class I-mediated cytotoxicity does not induce apoptosis in muscle fibers nor in inflammatory T cells: studies in patients with polymyositis, dermatomyositis, and inclusion body myositis.
    Schneider C; Gold R; Dalakas MC; Schmied M; Lassmann H; Toyka KV; Hartung HP
    J Neuropathol Exp Neurol; 1996 Dec; 55(12):1205-9. PubMed ID: 8957443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochrome c oxidase deficiencies in the muscle of patients with inflammatory myopathies.
    Chariot P; Ruet E; Authier FJ; Labes D; Poron F; Gherardi R
    Acta Neuropathol; 1996; 91(5):530-6. PubMed ID: 8740235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.